Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Drug Resistance

  Free Subscription


2 Antimicrob Agents Chemother
1 Infect Control Hosp Epidemiol
20 Int J Antimicrob Agents
3 J Antimicrob Chemother
1 J Infect Dis
1 J Med Microbiol
1 Nature
3 PLoS Genet
1 PLoS One
2 Sex Transm Infect

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. CRANE JK, Alvarado CL, Sutton MD
    Role of the SOS Response in the Generation of Antibiotic Resistance In Vivo.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00013.
    PubMed         Abstract available

  2. REHMAN A, Jeukens J, Levesque RC, Lamont IL, et al
    Gene-gene interactions dictate ciprofloxacin resistance in Pseudomonas aeruginosa and facilitate prediction of resistance phenotype from genome sequence data.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.02696.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  3. PASCALE R, Bussini L, Gaibani P, Bovo F, et al
    Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: multicenter before-after cross sectional study.
    Infect Control Hosp Epidemiol. 2021 Apr 16:1-25. doi: 10.1017/ice.2021.
    PubMed         Abstract available

    Int J Antimicrob Agents

  4. NOEL A, Attwood M, Bowker K, MacGowan A, et al
    The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection.
    Int J Antimicrob Agents. 2020;56:105985.
    PubMed         Abstract available

  5. STRAZZULLA A, Iordache L, de Pontfarcy A, Pitsch A, et al
    beta-Lactam allergy and risk of multidrug-resistant bacteria in the intensive care unit: A cohort study.
    Int J Antimicrob Agents. 2020;56:105979.
    PubMed         Abstract available

  6. CAI T, Tamanini I, Mattevi D, Verze P, et al
    Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study.
    Int J Antimicrob Agents. 2020;56:105935.
    PubMed         Abstract available

    Quasispecies dynamics and clinical significance of hepatitis C virus (HCV) antiviral resistance.
    Int J Antimicrob Agents. 2020;56:105562.
    PubMed         Abstract available

  8. KOSTYANEV T, Xavier BB, Garcia-Castillo M, Lammens C, et al
    Phenotypic and Molecular Characterisations of Carbapenem-resistant Acinetobacter baumannii Isolates Collected within the EURECA Study.
    Int J Antimicrob Agents. 2021 Apr 19:106345.
    PubMed         Abstract available

  9. HUANG PH, Cheng YH, Chen WY, Juan CH, et al
    Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae.
    Int J Antimicrob Agents. 2021 Apr 14:106342.
    PubMed         Abstract available

  10. CREMET L, Leroy AG, Muller D, Delanou S, et al
    Antibiotic Resistance Heterogeneity and LasR Diversity within Pseudomonas aeruginosa Populations from Pneumonia in Intensive Care Unit Patients.
    Int J Antimicrob Agents. 2021 Apr 12:106341.
    PubMed         Abstract available

  11. SCUDELLER L, Righi E, Chiamenti M, Bragantini D, et al
    Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    Int J Antimicrob Agents. 2021 Apr 12:106344.
    PubMed         Abstract available

  12. TANG SSL, Chee E, Teo JQ, Chlebicki MP, et al
    Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
    Int J Antimicrob Agents. 2021 Apr 12:106340.
    PubMed         Abstract available

  13. DOGAN O, Yesilkaya A, Menekse S, Guler O, et al
    Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
    Int J Antimicrob Agents. 2020;56:105992.
    PubMed         Abstract available

  14. KAVANAUGH LG, Flanagan JN, Steck TR
    Reciprocal antibiotic collateral sensitivity in Burkholderia multivorans.
    Int J Antimicrob Agents. 2020;56:105994.
    PubMed         Abstract available

  15. IANNACCONE M, Boattini M, Bianco G, Cavallo R, et al
    Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa.
    Int J Antimicrob Agents. 2020;56:106066.

  16. ANDRE-GARNIER E, Hingrat QL, Marcelin AG, Reliquet V, et al
    Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
    Int J Antimicrob Agents. 2020;56:106039.

  17. FURLAN JPR, Savazzi EA, Stehling EG
    Widespread high-risk clones of multidrug-resistant extended-spectrum beta-lactamase-producing Escherichia coli B2-ST131 and F-ST648 in public aquatic environments.
    Int J Antimicrob Agents. 2020;56:106040.
    PubMed         Abstract available

  18. PEREZ-VAZQUEZ M, Sola-Campoy PJ, Zurita AM, Avila A, et al
    Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2.
    Int J Antimicrob Agents. 2020;56:106026.
    PubMed         Abstract available

  19. SANTORO MM, Fornabaio C, Malena M, Galli L, et al
    Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen.
    Int J Antimicrob Agents. 2020;56:106027.
    PubMed         Abstract available

  20. GAURAV A, Kothari A, Omar BJ, Pathania R, et al
    Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia.
    Int J Antimicrob Agents. 2020;56:106022.
    PubMed         Abstract available

  21. BARBOSA F, Pinto E, Kijjoa A, Pinto M, et al
    Targeting antimicrobial drug resistance with marine natural products.
    Int J Antimicrob Agents. 2020;56:106005.
    PubMed         Abstract available

  22. WILLCOCKS SJ, Cia F, Francisco AF, Wren BW, et al
    Revisiting aminocoumarins for the treatment of melioidosis.
    Int J Antimicrob Agents. 2020;56:106002.
    PubMed         Abstract available

  23. CHEN L, Han D, Tang Z, Hao J, et al
    Co-existence of the oxazolidinone resistance genes cfr and optrA on two transferable multi-resistance plasmids in one Enterococcus faecalis isolate from swine.
    Int J Antimicrob Agents. 2020;56:105993.
    PubMed         Abstract available

    J Antimicrob Chemother

  24. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed         Abstract available

  25. AMBROSE SJ, Hall RM
    Identification of the dfrA4 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226985. doi: 10.1093.

  26. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed         Abstract available

    J Infect Dis

  27. GOLOB JL, Rao K
    Signal vs. noise: how to analyze the microbiome and make progress on antimicrobial resistance.
    J Infect Dis. 2021 Apr 21. pii: 6242384. doi: 10.1093.

    J Med Microbiol

  28. KHAMARI B, Kumar P, Pradeep BE
    Resistance to nitrofurantoin is an indicator of extensive drug-resistant (XDR) Enterobacteriaceae.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available


  29. Babies' gut bacteria teem with antibiotic-resistance genes.
    Nature. 2021 Apr 21. pii: 10.1038/d41586-021-01051.

    PLoS Genet

  30. KNOPP M, Babina AM, Gudmundsdottir JS, Douglass MV, et al
    A novel type of colistin resistance genes selected from random sequence space.
    PLoS Genet. 2021;17:e1009227.
    PubMed         Abstract available

  31. CHATTERJEE A, Willett JLE, Dunny GM, Duerkop BA, et al
    Phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system dependent inhibition of bystander bacteria.
    PLoS Genet. 2021;17:e1009204.
    PubMed         Abstract available

  32. ROTH C, Murray D, Scott A, Fu C, et al
    Pleiotropy and epistasis within and between signaling pathways defines the genetic architecture of fungal virulence.
    PLoS Genet. 2021;17:e1009313.
    PubMed         Abstract available

    PLoS One

  33. SUWONO B, Eckmanns T, Kaspar H, Merle R, et al
    Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017.
    PLoS One. 2021;16:e0244413.
    PubMed         Abstract available

    Sex Transm Infect

  34. BROAD CE, Furegato M, Harrison MA, Pond MJ, et al
    High prevalence of coinfection of azithromycin-resistant Mycoplasma genitalium with other STIs: a prospective observational study of London-based symptomatic and STI-contact clinic attendees.
    Sex Transm Infect. 2021;97:63-68.
    PubMed         Abstract available

  35. LAUMEN JGE, van Alphen LB, Maduna LD, Hoffman CM, et al
    Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa.
    Sex Transm Infect. 2021;97:152-156.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.